United States· US:57237-091_3c365d52-7f5f-477f-8342-4c507b2a7936
Trandolapril
A trandolapril product containing trandolapril, registered in United States by Rising Pharma Holdings, Inc.. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Trandolapril is registered in 12 of 19 countries.
Countries holding a registration under ATC C09AA10 (trandolapril), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Trandolapril · ATC C09AA10
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of trandolapril costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trandolapril · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- ES Spain$0.38
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRANDOLAPRIL
- Manufacturer
- Rising Pharma Holdings, Inc.
- Country
- United States (US)
- ATC code
- C09AA10
- ATC class
- Trandolapril
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc115723709101100 TABLET in 1 BOTTLE (57237-091-01)
- ndc1157237-091-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
282 interactions on record for trandolapril.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trandolapril · interactions on record
282 records
- 11 severe
- 165 moderate
- 17 minor
- 16 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
73 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trandolapril in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGopten 1mg capsulesAbbott Laboratories Ltd
- CanadaAURO-TRANDOLAPRILAURO PHARMA INC
- PolandGopten 0,5Viatris Healthcare Sp. z o.o.
- CzechiaGOPTENVIATRIS HEALTHCARE LIMITED, Dublin
- FranceODRIK 2 mg, géluleVIATRIS MEDICAL
- FinlandGoptenAbbott Scandinavia AB
- IrelandOdrik 1mg Hard CapsulesViatris Healthcare Limited
- SpainGOPTEN 0,5 mg CAPSULAS DURASViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Bulgaria · Гоптен
- Czechia · Gopten
- Germany · Udrik
- Denmark · Odrik, Trandolapril "viatris"
- Estonia · Gopten
- Spain · Gopten
- France · Odrik, Trandolapril Biogaran
- United Kingdom (Northern Ireland) · Trandolapril Accord-Uk, Trandolapril Generics [uk]
- Greece · Daman, Testolan
- Croatia · Gopten, Trandolapril Pharmas
- Hungary · Gopten, Gopten Mite
- Ireland · Odrik
- Italy · Gopten, Trandolapril Mylan Generics
- Lithuania · Gopten, Trandolapril Ingen Pharma
- Luxembourg · Udrik
- Latvia · Gopten
- Poland · Gopten
- Portugal · Gopten, Trandolapril Generis
- Romania · Trandolapril Arena
- Slovenia · Gopten
- Slovakia · Gopten, Trandolapril Ratiopharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/79b9ee62-9ed2-422e-b1c9-62b0c085efb3 GET /v1/drugs/79b9ee62-9ed2-422e-b1c9-62b0c085efb3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "4",
"substance": "TRANDOLAPRIL",
"productndc": "57237-091",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA078438",
"marketing_category": "ANDA"
}See everything about trandolapril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.